COMMUNIQUÉS West-GlobeNewswire

-
Anosh Inc. Foundation Reflects on a Year of Transformative Impact in 2023
16/07/2024 -
Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer
16/07/2024 -
FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
16/07/2024 -
RosenCare and PeopleOne Health Join Forces to Transform Healthcare Market in Florida
16/07/2024 -
The International Myeloma Foundation Mourns the Passing of IMF Board Member and Support Group Leader Jack Aiello
16/07/2024 -
Trethera Receives $2M NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
16/07/2024 -
Senti Bio Announces Reverse Stock Split
16/07/2024 -
CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial
16/07/2024 -
Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada
16/07/2024 -
EssilorLuxottica: Second-Quarter and First-Half 2024 Results Conference Call Invitation
15/07/2024 -
EssilorLuxottica: Second-Quarter and First-Half 2024 Results Conference Call Invitation
15/07/2024 -
Panthera BioSolutions Launches Pharmaceutical Good Manufacturing Practice (GMP) Foundational Training Course with Dallas College to Advance Workforce Talent Pipeline in North Texas
15/07/2024 -
Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine
15/07/2024 -
SoldierStrong Marks 15ᵗʰ Anniversary With Focus on New Approaches to Help Veterans Take Their Next Steps Forward
15/07/2024 -
Third Year in a Row, LifeLabs Named by Forbes as one of Canada's Best Employers for Diversity
15/07/2024 -
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
15/07/2024 -
IR-MED Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers
15/07/2024 -
GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series
15/07/2024 -
SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
15/07/2024
Pages